INSIGHTS ON SOLID DOSE MANUFACTURING

• Navigating OSD Formulation Development And Leveraging CDMO Partnership

  Collaborating with an experienced CDMO can provide the expertise and facilities needed to navigate oral solid dose formulation complexities and ensure compliance with regulatory frameworks.

• The Critical Role Of Weight Uniformity In Tablet Manufacturing

  For tablet manufacturers, tablet weight uniformity plays an essential role in ensuring pharmaceutical products deliver accurate amounts of key ingredients in a formulation.

• Liquids, Soft Foods As Vehicles For Enteric Coated Bead Drug Product

  Take a deeper look at the challenges and solutions involved in creating a child-friendly medication delivery system, and learn about the importance of collaboration and meticulous scientific processes.

• The Future Of Oral Solid Dose Development And Innovation

  Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

• Optimizing DPI Production: Filling Technologies For Precision And Performance

  4/16/2025

  Developing effective dry powder inhalers requires expertise across multiple disciplines, from particle engineering and device technology to manufacturing science and regulatory knowledge.

• Tablet Consistency And Punch Length – A Pragmatic Perspective For European Manufacturers

  10/7/2025

  Tablet consistency relies on a balance of formulation, press mechanics, and tooling. Learn why punch length tolerance is often overstated and what other critical factors truly drive quality and uniformity.

• Overload Setting – Tricks And Techniques

  9/23/2024

  Learn how a partner company that is committed to assisting manufacturers with calibration and optimal set-point establishment can serve as a valuable resource in achieving optimal tablet production.

• A Technology Driven CDMO & Trusted Manufacturing Partner

  7/18/2024

  Whether it's through extended release formulations or titratable dosage forms, we are dedicated to addressing the specific needs of different patient populations, including pediatrics and geriatrics.

• Customized Release Through Dispersed Dosage Formats

  6/13/2024

  Typically, dosage format is based on the target product profile: how the developer envisions the product best addressing a clinical indication by maintaining population-wide efficacy.